Page last updated: 2024-11-05

tyramine and Akinetic-Rigid Variant of Huntington Disease

tyramine has been researched along with Akinetic-Rigid Variant of Huntington Disease in 2 studies

Research Excerpts

ExcerptRelevanceReference
"In patients with Huntington's disease, there is a mutation in the gene encoding the protein huntingtin, which results in an expanded polyglutamine sequence leading to degeneration of the basal ganglia."1.33Enhanced toxicity to the catecholamine tyramine in polyglutamine transfected SH-SY5Y cells. ( Dimayuga, ER; Keller, JN; Maragos, WF; Smith, RR, 2005)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Smith, RR1
Dimayuga, ER1
Keller, JN1
Maragos, WF1
Dill, RE1
Dorris, RL1
Phillips-Thonnard, I1

Other Studies

2 other studies available for tyramine and Akinetic-Rigid Variant of Huntington Disease

ArticleYear
Enhanced toxicity to the catecholamine tyramine in polyglutamine transfected SH-SY5Y cells.
    Neurochemical research, 2005, Volume: 30, Issue:4

    Topics: Catalase; Cell Line; Deferoxamine; DNA; Dopamine; Humans; Huntington Disease; Hydrogen Peroxide; Iro

2005
A pharmacologic model of Huntington's chorea.
    The Journal of pharmacy and pharmacology, 1976, Volume: 28, Issue:8

    Topics: Animals; Carbachol; Catheterization; Clozapine; Corpus Striatum; Disease Models, Animal; Dyskinesia,

1976